|
|
Neural Mechanisms Supporting Implicit and Explicit Sensorimotor Learning |
| 1F31NS120448-01A1 |
|
NINDS |
2022 |
|
|
Personalizing tDCS Dose in Healthy Adults and Chronic Ischemic Stroke |
| 1F31NS126019-01 |
|
NINDS |
2022 |
|
|
Stress Biology and Psychosocial stressors as mechanisms for Racial Health Disparities in Neural and Clinical Impairments of Multiple Sclerosis |
| 1F99NS125815-01A1 |
|
NINDS |
2022 |
|
|
Early post-stroke biomarkers for motor rehabilitation outcomes |
| 1K23NS121635-01A1 |
|
NINDS |
2022 |
|
|
The structural underpinnings of disinhibition in dystonia |
| 1K23NS124978-01A1 |
|
NINDS |
2022 |
|
|
Comprehensive Deep Phenotyping and Multi-omics to Develop Clinical and Molecular Biomarkers for MeCP2-related Diseases |
| 1K23NS125126-01A1 |
|
NINDS |
2022 |
|
|
MRI paramagnetic rim lesions as biomarkers and agents of neurodegeneration in multiple sclerosis |
| 1K23NS126718-01 |
|
NINDS |
2022 |
|
|
Neural mechanisms of spatial representations beyond the self |
| 1K99NS126715-01 |
|
NINDS |
2022 |
|
|
Neurovascular consequences of non-pulsatile flow from left ventricular assist devices |
| 1R01NS121364-01A1 |
|
NINDS |
2022 |
|
|
Progressive resistance exercise and dystonia pathophysiology. |
| 1R01NS122943-01A1 |
|
NINDS |
2022 |